The Association of Radiation Oncologists of India (AROI) convened in Madurai to discuss the integration of precision oncology and multidisciplinary care to enhance cancer patient outcomes.

  • AROI Tamil Nadu & Puducherry Chapter hosted its annual conference in Madurai.
  • Over 300 delegates, including top radiation oncologists, participated.
  • Focus on 'Precision Oncology': Right treatment, right patient, right time, and right dose.
  • Emphasis on patient-centric care combining empathy with advanced technology.

The Association of Radiation Oncologists of India (AROI), Tamil Nadu & Puducherry Chapter, successfully organized its annual conference on September 12 and 13 in Madurai. The event served as a high-level gathering for approximately 300 delegates, bringing together leading radiation oncologists and medical professionals from across India to discuss the evolving landscape of cancer care.

The primary objective of the conference was to bridge the gap between international advancements and grassroots implementation. By sharing the latest breakthroughs in radiation oncology, the forum aimed to provide cancer patients with a better quality of life and higher cure rates through updated treatment strategies and shared clinical experiences.

Why This Matters

BozokMedia analysis indicates that the shift toward precision oncology represents a paradigm shift in global healthcare. Moving away from generic chemotherapy and radiation, precision oncology utilizes molecular profiling to tailor treatments to the individual's genetic makeup, significantly reducing toxicity and increasing efficacy.

Chief Guest Dr. P. Vijay Anand Reddy, Director of the Apollo Cancer Centre, Hyderabad, delivered a compelling keynote on the evolution of oncology. He asserted that modern treatment is moving toward an era of maximum precision, where the goal is to deliver the right technology and dose to the right patient at the optimal moment.

Precision at its best is not merely about advanced technology; it is about bringing together expertise, evidence and empathy to deliver the best possible care to every patient.

Dr. Reddy further elaborated that precision must extend beyond the machinery. He highlighted the necessity of accurate diagnosis, precise staging, individualized treatment planning, and a multidisciplinary approach that integrates surgery, systemic therapy, and radiotherapy. Central to this entire process, he argued, must be the patient.

The event featured a presidential address by Srinivasan Krishnan (President, AROI TN and PY) and a secretary's address by Rajesh Balakrishnan. The proceedings concluded with a vote of thanks proposed by the Organizing Secretary, K. Mahalakshmi Prasad.

Did You Know?: Precision oncology often employs 'Pharmacogenomics', which studies how a person's genes affect their response to specific cancer drugs.

Frequently Asked Questions

Q1: What is Precision Oncology?
A: It is a personalized approach to cancer treatment that uses the genetic profile of the patient and the tumor to guide the selection of therapies.

Q2: What was the key takeaway from the AROI conference?
A: The key takeaway was that while technology is vital, true precision in cancer care requires a combination of evidence-based medicine and patient-centric empathy.